Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Spotify Technology (SPOT) vs Zoetis Inc (ZTS) Price & Performance

Spotify TechnologyTrade
Zoetis IncTrade

Price performance (Past 24H)

Key statistics

Spotify Technology vs Zoetis Inc — how do they compare? Spotify Technology trades at $529.14 (market cap $108.22B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Spotify Technology is far larger — about 3.6× Zoetis Inc's market cap, and Zoetis Inc pays a 2.9% dividend while Spotify Technology pays none. Which is the better fit depends on your goals — on Pluang, investors hold Spotify Technology for 111 Days and Zoetis Inc for 70 Days on average.

SPOTZTS
Market Cap
$108.22B$30.20B
Volume
1,655,7966,175,327
Sector
MediaHealth
52-Week High
$692.04$147.53
52-Week Low
$412.75$69.09
Typical Hold Time
111 Days70 Days
Enterprise Value
$98.23B$37.76B
Dividend Yield
—2.9%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Spotify Technology

Spotify (SPOT) trades at $526.42, up 2.63% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamental improvement with revenue growth from $15.7B to $17.2B in 2025 and net income surging to $2.2B. Recent earnings show mixed results with Q2 2026 missing expectations, but analyst sentiment remains overwhelmingly positive with 62% buy ratings and a $606.50 consensus target.

The outlook remains favorable with expanding gross margins and positive cash flow trends, though competition and market volatility present risks. With strong institutional support and upcoming Q3 earnings on October 22, 2026, SPOT offers growth potential but requires monitoring of execution against elevated valuation multiples.

Zoetis Inc

Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal despite mixed moving averages and oscillators. The company shows strong profitability with a 27.69% net income margin and 64.91% ROE, though recent quarterly earnings have been inconsistent. Analyst consensus is a $87.33 price target with no sell ratings. Recent news highlights near-term headwinds in U.S. companion animal sales but underscores long-term resilience and undervaluation.

ZTS presents a compelling value opportunity with a low P/E of 11.92 and robust margins, but faces risks from competitive pressures and volatile earnings. Upside potential exists if the company executes on international growth and maintains its industry-leading profitability, though investors should monitor Q3 2026 results for confirmation of recovery trends.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SPOT
13% Buy87% Sell
Avg holding period · 111 Days
ZTS

No sentiment data available yet.

Top news

Latest headlines on both assets

About Spotify Technology

Spotify Technology S.A. provides music streaming services. The Company offers commercial-free music and ad-supported services to subscribers. Spotify Technology serves clients worldwide.

Read more on SPOT →

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS →